Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Human keratinocytes do not naturally respond to androgens.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Precise objectives can improve student achievement in health education.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Androgens regulate Sertoli cells and affect fertility through specific receptors and coregulators.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

Targeting CXCL12 may help treat hair loss caused by androgens.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.